Roper Technologies

ROP · NASDAQ

$398.21+$14.71 (+3.84%)TodayMarket closed · Oct 20, 6:02 PM ET

Prev close $383.50

ROP analyst rating

HoldConsensus of 19 analysts over the last 12 months. 47% rate it a buy.

Strong buy1
Buy8
Hold6
Underperform4
Sell0

12-month price target · 17 analysts

Average $452.55 (+13.6% upside)

Low: $338.35
Now: $398.21
High: $577.50

Upgrades and downgrades

The latest rating actions, newest first

ROP analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
RBC Capital	Aug 18, 2026	Maintains	Sector Perform	$417.00	57%
Argus Research	Aug 6, 2026	Upgrade	Hold → Buy	$450.00	65%
JP Morgan	Jul 29, 2026	Maintains	Underweight	$397.00 → $415.00	64%
RBC Capital	Jul 24, 2026	Maintains	Sector Perform	$407.00 → $417.00	57%
Piper Sandler	Jul 24, 2026	Maintains	Overweight	$540.00 → $526.00	41%
BMO Capital	Jul 10, 2026	Initiates	Market Perform	$393.00	51%
Barclays	Apr 24, 2026	Maintains	Underweight	$380.00 → $373.00	65%
RBC Capital	Apr 24, 2026	Maintains	Sector Perform	$393.00 → $407.00	57%
Baird	Apr 24, 2026	Maintains	Outperform	$464.00 → $470.00	100%
Piper Sandler	Apr 24, 2026	Maintains	Overweight	$530.00 → $540.00	41%

The case for and against

Updated Oct 14, 2026

Bull case

Roper Technologies is attractive because it combines a decentralized portfolio of 30 niche businesses with a high-quality mix of software and network assets, as over three-fourths of revenue comes from software products and more than two-thirds is recurring or reoccurring. In 2Q26, it delivered a modest operating beat, 118% free cash flow conversion, 11% year-over-year FCF growth, and 6% organic growth, while raising 2026 cash EPS guidance to $22.15-$22.30 and organic growth to about 6%. The outlook is further supported by improving signs in DAT, Neptune, and Deltek, plus strong margin expansion, AI-driven product momentum, and continued disciplined capital allocation through buybacks and future M&A.

Bear case

Roper Technologies is viewed negatively because its premium valuation appears vulnerable if the market’s expectation for accretive M&A and durable software multiple expansion proves too optimistic, especially as management signals a shift from $1.2 billion of 2Q26 buybacks toward de-leveraging ahead of future acquisitions. Despite solid 2Q26 results — $2,109 million of revenue, 5% organic growth, and 38.7% adjusted EBITDA margin — growth was partly offset by nonrecurring revenue headwinds and segment margin pressure from inflation and mix shifts, while AI disruption remains an emerging risk to the company’s software-heavy model. The stock also trades at 14.7x 2027 EPS and 12.7x 2027 EV/EBITDA, both at meaningful discounts to peers, but the outlook remains constrained by slowing buybacks, prolonged M&A uncertainty, and a broader rotation away from high-quality compounders.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.